Last edition
News about Clinical Trials
Wegovy Outperforms Tirzepatide, Slashes Cardiovascular Risk by 57 Percent
Wegovy showed a significant 29 percent risk reduction for heart attack, stroke and death from any cause compared with Tirzepatide (over an average follow-up of 8.3 months for Wegovy and 8.6 months for Tirzepatide.
Clinical Trials | 01/09/2025 | By Dineshwori
Amgen Partners with Veeva Systems to Drive Innovation in Clinical Trials
Veeva Systems, a leading provider of cloud-based software, data, and consulting services for the life sciences industry, has announced a strategic collaboration with biotechnology giant Amgen to advance clinical trial innovation.
Clinical Trials | 01/09/2025 | By Darshana | 108
Prometheus Laboratories Collaborates with Celltrion for Anser Testing
Prometheus is the first specialty lab to validate TDM testing for both intravenous and subcutaneous infliximab, supporting the growing demand for at-home treatment options.
Clinical Trials | 28/08/2025 | By Dineshwori
MMS Holdings (MMS) has been selected by Friends of Cancer Research (Friends) to support the development of practical decision frameworks to inform the interpretation of interim overall survival (OS) data in oncology clinical trials.
Clinical Trials | 20/08/2025 | By Dineshwori
Galvanize Therapeutics Begins Clinical Study of Aliya Pulsed Electric Field Ablation
Galvanize Therapeutics has announced the enrollment of the first patient in the PROPEL Registry, a multicenter observational study designed to evaluate the clinical application, safety, and outcomes of the Aliya Pulsed Electric Field (PEF) ablation system for soft tissue lesions.
Clinical Trials | 18/08/2025 | By Dineshwori
The oral beta-lactam/beta-lactamase inhibitor (BL/BLI) combination is phase 3-ready and being developed as a potential treatment for complicated urinary tract infections (cUTI), including pyelonephritis.
Clinical Trials | 16/08/2025 | By Darshana | 103
Novartis Advances Ianalumab Toward Approval for Sjogren's Disease After Phase III Success
Novartis has reported positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with active Sjogren's disease.
Clinical Trials | 11/08/2025 | By Dineshwori
Sun Pharmaceutical Industries has reported positive top-line results from two Phase 3 trials (INSPIRE-1 and INSPIRE-2), demonstrating that ILUMYA (tildrakizumab 100 mg) significantly improved symptoms of active psoriatic arthritis over 24 weeks compared to placebo.
Clinical Trials | 21/07/2025 | By Mrinmoy Dey | 175
CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal
For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.
Clinical Trials | 11/07/2025 | By Dineshwori | 164
Klotho Neurosciences Advances Gene Therapy Manufacturing for ALS Treatment
Klotho Neurosciences has announced the initiation of manufacturing and process development for KLTO-202, its investigational gene therapy targeting ALS, with plans to begin clinical trials by Q3 next year.
Clinical Trials | 02/07/2025 | By Mrinmoy Dey | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy